Laura and Isaac Perlmutter Cancer Center ( Site 1121) — New York, New York

Laura and Isaac Perlmutter Cancer Center ( Site 1121) is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Laura and Isaac Perlmutter Cancer Center ( Site 1121) has participated in 1 clinical trials.

Therapeutic areas: Carcinoma, Squamous Cell, Skin Neoplasms.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Laura and Isaac Perlmutter Cancer Center ( Site 1121)?

Laura and Isaac Perlmutter Cancer Center ( Site 1121) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Laura and Isaac Perlmutter Cancer Center ( Site 1121) conducted?

Laura and Isaac Perlmutter Cancer Center ( Site 1121) has 1 clinical trials on record. Their work covers Carcinoma, Squamous Cell, Skin Neoplasms.

Is Laura and Isaac Perlmutter Cancer Center ( Site 1121) accredited by Crixeo Health?

Laura and Isaac Perlmutter Cancer Center ( Site 1121) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Laura and Isaac Perlmutter Cancer Center ( Site 1121)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.